Provided by Tiger Trade Technology Pte. Ltd.

Babson Capital Corporate Investors

19.13
+0.15000.79%
Post-market: 19.130.00000.00%16:15 EDT
Volume:37.43K
Turnover:715.61K
Market Cap:392.14M
PE:10.92
High:19.30
Open:19.04
Low:18.95
Close:18.98
52wk High:22.56
52wk Low:16.21
Shares:20.50M
Float Shares:20.50M
Volume Ratio:1.03
T/O Rate:0.18%
Dividend:1.60
Dividend Rate:8.36%
EPS(TTM):1.75
EPS(LYR):1.37
ROE:10.22%
ROA:4.44%
PB:1.10
PE(LYR):13.99

Loading ...

Barings Serves as Agent on Senior Secured Credit Facilities for Quad-c’s Armstrong Transport Acquisition

Reuters
·
Jul 22

LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment

GlobeNewswire
·
Jul 14

FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease

GlobeNewswire
·
Jul 14

Barings leads senior secured credit facilities backing CIVC acquisition of Nationwide Legal Services

Reuters
·
Jun 22

Barings provides senior secured credit facilities for DBAG Fund VIII investment in Hipp Technology Group

Reuters
·
Jun 09

Barings leads secured credit facilities for Francisco Partners’ Thinventory refinancing

Reuters
·
Jun 03

Barings to sub-advise Pacer fixed income ETFs focused on CLO, secured credit opportunities

Reuters
·
Jun 02

INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial

GlobeNewswire
·
Jun 02

Barings Corporate Investors Q1 net investment income rises slightly

Reuters
·
May 15

Barings Corporate Investors Q1 Dividend USD 0.4

THOMSON REUTERS
·
May 15

INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease

GlobeNewswire
·
May 14

India's Wholesale Inflation Accelerates in April

MT Newswires Live
·
May 14

Barings Global Short Duration High Yield Fund declares May distribution of $0.1223 a share

Reuters
·
May 12

Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease

GlobeNewswire
·
May 08

Press Release: Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update

Dow Jones
·
May 08

India Wholesale Prices Rise in March on Fuel Costs

MT Newswires Live
·
Apr 15

New Alzheimer's research shows the disease affects men and women differently. What it could mean for testing and care.

Dow Jones
·
Apr 15

Alzheimer's affects men and women's brains differently, new research shows. What it could mean for testing and care.

Dow Jones
·
Apr 14

NFI Names Rob Marion President as It Re-establishes MCI as Standalone Unit

TIPRANKS
·
Apr 03

Press Release: Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update

Dow Jones
·
Mar 26